Evolent Health IncEVH
Price$3.39

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.1B-17.9% YoYTTM through 30 Jun 2026
Net Income -$505MTTM through 30 Jun 2026
Free Cash Flow $4.8MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-15.1%
Operating Margin-21.9%
Net Margin-24.1%

Returns

-131.8%ROE
-25.6%ROA

Balance Sheet Health

Debt / Equity2.34x
Current Ratio1.30x
Net Debt$818.6M
Cash & Equivalents$115.7M

Quality Metrics

Altman Z-Score-0.39
Piotroski F-Score4 / 9
FCF Margin0.2%
Rule of 4019.5
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $1.9B
Diluted EPS-$4.57TTM
'19'20'21'22'23'24'25
FY2025: $-4.68

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.